Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients

Fu-Chao Liu1 Department of Anesthesiology, Chang Gung Memorial Hospital;2 College of Medicine

Huan-Tang Lin1 Department of Anesthesiology, Chang Gung Memorial Hospital;2 College of Medicine

Jr-Rung Lin1 Department of Anesthesiology, Chang Gung Memorial Hospital;2 College of Medicine;3 Clinical Informatics and Medical Statistics Research Center and Graduate Institute of Clinical Medicine, Chang Gung University, Taoyuan, Taiwan

Huang-Ping Yu1 Department of Anesthesiology, Chang Gung Memorial Hospital;2 College of MedicineCorrespondence[email protected]

Pages 1043-1051 | Published online: 18 Aug 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

LingQXuXWangBLiLZhengSThe origin of new-onset diabetes after liver transplantation: liver, islets, or gut?Transplantation2016100480881326910326
PubMed Web of Science ®Google Scholar
LiDWLuTFHuaXWRisk factors for new onset diabetes mellitus after liver transplantation: a meta-analysisWorld J Gastroenterol201521206329634026034369
PubMed Web of Science ®Google Scholar
KesirajuSParitalaPRao ChUMSahariahSNew onset of diabetes after transplantation – an overview of epidemiology, mechanism of development and diagnosisTranspl Immunol2014301525824184293
PubMed Web of Science ®Google Scholar
LiuFCLinJRChenHPTsaiYFYuHPPrevalence, predictive factors, and survival outcome of new-onset diabetes after liver transplantation: a population-based cohort studyMedicine20169525e382927336869
PubMed Web of Science ®Google Scholar
BamgbolaOMetabolic consequences of modern immunosuppressive agents in solid organ transplantationTher Adv Endocrinol Metab20167311012727293540
PubMed Web of Science ®Google Scholar
Kidney Disease: Improving Global Outcomes Transplant Work GroupKDIGO clinical practice guideline for the care of kidney transplant recipientsAm J Transplant20099Suppl 3S1S155
PubMedGoogle Scholar
de Mare-BredemeijerELMetselaarHJOptimization of the use of calcineurin inhibitors in liver transplantationBest Pract Res Clin Gastroenterol2012261859522482528
PubMed Web of Science ®Google Scholar
MalvezziPRostaingLThe safety of calcineurin inhibitors for kidney-transplant patientsExpert Opin Drug Saf201514101531154626329325
PubMed Web of Science ®Google Scholar
WebberABVincentiFAn update on calcineurin inhibitor-free regimens: the need persists, but the landscape has changedTransplantation2016100483684327003097
PubMed Web of Science ®Google Scholar
MoiniMSchilskyMLTichyEMReview on immunosuppression in liver transplantationWorld J Hepatol20157101355136826052381
PubMed Web of Science ®Google Scholar
NeubergerJAn update on liver transplantation: a critical reviewJ Autoimmun201666515926350881
PubMed Web of Science ®Google Scholar
HaddadEMMcAlisterVCRenoufEMalthanerRKjaerMSGluudLLCyclosporin versus tacrolimus for liver transplanted patientsT Cochrane Database Syst Rev20064CD005161
Google Scholar
GeisslerEKSchnitzbauerAAZulkeCSirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trialTransplantation2016100111612526555945
PubMed Web of Science ®Google Scholar
EkbergHTedesco-SilvaHDemirbasAReduced exposure to calcineurin inhibitors in renal transplantationN Engl J Med2007357252562257518094377
PubMed Web of Science ®Google Scholar
SilvaHTJrYangHCMeier-KriescheHULong-term follow-up of a phase III clinical trial comparing tacrolimus extended- release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipientsTransplantation201497663664124521771
PubMed Web of Science ®Google Scholar
SongJLGaoWZhongYMinimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantationWorld J Gastroenterol20162262133214126877618
PubMed Web of Science ®Google Scholar
LorhoRHardwigsenJDumortierJRegression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: results of a pilot studyClin Res Hepatol Gastroenterol2011356–748248821530445
PubMed Web of Science ®Google Scholar
DumortierJBernardSBouffardYBoillotOConversion from tacrolimus to cyclosporine in liver transplanted patients with diabetes mellitusLiver Transpl200612465966416496279
PubMed Web of Science ®Google Scholar
Ramos-CebrianMTorregrosaJVGutierrez-DalmauAOppenheimerFCampistolJMConversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantationTransplant Proc20073972251225317889154
PubMed Web of Science ®Google Scholar
PalepuSPrasadGVNew-onset diabetes mellitus after kidney transplantation: current status and future directionsWorld J Diabetes20156344545525897355
PubMed Web of Science ®Google Scholar
KrenzienFElKhalAQuanteMA rationale for age-adapted immunosuppression in organ transplantationTransplantation201599112258226826244716
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date